Skip to content

Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities

Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05651581
Enrollment
200
Registered
2022-12-15
Start date
2023-05-24
Completion date
2023-08-24
Last updated
2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monkey Pox

Brief summary

The study team will create an online module via the REDCap platform. The module will include around 5 videos and several infographics covering the topics of symptoms, transmission, prevention, vaccination, and treatment of the monkeypox virus. Surveys assessing the primary and secondary study endpoints will be given to participants before and after the module. The purpose of the study is to assess the efficacy and acceptability of an educational presentation on monkeypox in a cohort of individuals recruited from Rainbow Health and to secondarily assess participant risk perception, intention to vaccinate, and confidence in public health initiatives.

Interventions

OTHEROnline module

online module including around 5 videos and several infographics covering the topics of symptoms transmission, prevention, vaccination, and treatment of the monkeypox virus.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Individuals who are 18 years and older * Individuals able to read and write in English

Exclusion criteria

* Unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of interventionbaselineEfficacy of intervention will be measured by changes in knowledge using a survey
Acceptabilityimmediately after interventionAcceptability will be measured by a validated questionnaire based on the Theoretical Framework of Acceptability.

Secondary

MeasureTime frameDescription
risk perceptionbaselinequestionnaire
intention to vaccinatebaselinequestionnaire
confidence in public health initiativesbaselinequestionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026